To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
21,389 Current newsrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Performance Materials realigns R&D
Merck expects strong growth impetus starting next year, as the company reported to analysts and investors at its Capital Markets Day. “2018 has been a challenging year for Merck. We have made future-oriented decisions that will lead to profitable growth as of next year,” said Stefan Oschmann, ...
Two Arizona State University professors are among the first recipients ofSomatic Cell Genome Editing (SCGE) grants from the National Institutes of Health Common Fund. The $2,600,000, five-year grant will fund the first study of the genome editing technology CRISPR to be used on a "human liver ...
New agreement supports sharing, innovation and openness
A new easy-to-use legal tool that enables open exchange of biological materials is launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks within ...
Business units to be relocated to California
Wyatt Technology announced that it has completed the acquisition of Superon GmbH, a manufacturer of Field Flow Fractionation (FFF) systems. Production, research and product development has been transferred to Wyatt’s Santa Barbara, CA headquarters which will enable the company to further enhance ...
Drug equipped polymer fibers
Drug-releasing textiles could, for instance, be used to treat skin wounds. Empa researchers are currently developing polymer fibers that can be equipped with drugs. The smart fibers recognize the need for therapy all by themselves and dose the active ingredients with precision and accuracy. For ...
Innovative process gives more control over free radicals
Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs. Researchers say this new method of forming reactive intermediates called ketyl radicals offers scientists a way to use catalysts to convert ...
Researchers have demonstrated an integrated technique for monitoring specific biomolecules - such as growth factors - that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics. Using microfluidic technology to advance the preparation of ...
Global Bioenergies announces that a new milestone has been met in the development of its Isobutene process. The company announces a yield exceeding 87% of the final target during the complete production phase, at laboratory scale. The productivity is also progressing quickly. Yield and ...
Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first batch ...
Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include additional cell lines. Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range of ...